In a newborn presenting with hypokalemia, hypertension, low renin and low aldosterone, is the serum cortisol level expected to be low?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, cortisol levels are expected to be LOW in this presentation

In a newborn with hypokalemia, hypertension, low renin and low aldosterone, serum cortisol is expected to be LOW, as this constellation strongly suggests congenital adrenal hyperplasia (CAH) due to 11-beta-hydroxylase or 17-alpha-hydroxylase deficiency.

Understanding the Clinical Picture

This specific presentation—hypertension with hypokalemia, suppressed renin AND suppressed aldosterone in a newborn—is pathognomonic for specific forms of CAH that cause mineralocorticoid excess through non-aldosterone pathways 1, 2.

The Mechanism

Congenital adrenal hyperplasia encompasses autosomal recessive inherited disorders caused by enzymatic defects in adrenal steroidogenesis, leading to LOW cortisol secretion 1. The two forms associated with this exact presentation are:

  • 11-beta-hydroxylase deficiency: Results in accumulation of 11-deoxycorticosterone (DOC), which activates the mineralocorticoid receptor, leading to low renin and low aldosterone hypertension with hypokalemia 1, 2

  • 17-alpha-hydroxylase deficiency: Similarly causes DOC accumulation with the same biochemical pattern 1, 2

Why Cortisol is Low

The enzymatic block in cortisol synthesis is the fundamental defect 1. The basal secretion rate of cortisol is low despite normal or elevated ACTH 3. This occurs because:

  1. The enzymatic deficiency prevents normal cortisol production
  2. ACTH rises in response to low cortisol (negative feedback)
  3. Precursors accumulate and are shunted to DOC production
  4. DOC provides the mineralocorticoid excess causing hypertension

Diagnostic Confirmation

The 2025 AHA/ACC guidelines specify that screening for CAH in this presentation should show "hypertension and hypokalemia with low or normal aldosterone and renin" 2. Confirmatory testing reveals:

  • 11-beta-hydroxylase deficiency: Elevated DOC, 11-deoxycortisol, and androgens 2
  • 17-alpha-hydroxylase deficiency: Decreased androgens and estrogen but elevated DOC and corticosterone 2

Critical Distinction from Other Conditions

This must be differentiated from:

  • Apparent mineralocorticoid excess: Here cortisol is NORMAL but acts as a mineralocorticoid due to 11-beta-hydroxysteroid dehydrogenase type 2 deficiency 1, 4, 5. The key difference is that cortisol levels and cortisol half-life are normal or even elevated 4

  • Primary aldosteronism: Would show HIGH aldosterone with suppressed renin—the opposite pattern 1

  • Liddle syndrome: Shows low aldosterone AND low renin, but cortisol is normal as this is a sodium channel defect, not an adrenal enzyme problem 1

Neonatal Considerations

Basal cortisol levels are generally lower in infancy than in childhood 6. However, in CAH with these enzyme deficiencies, cortisol is abnormally low even for neonatal standards. The 2018 Endocrine Society guidance notes that a cortisol <5 mg/dL with plasma ACTH more than two times the upper limit of normal makes primary adrenal insufficiency highly likely 6.

Clinical Pitfall

Do not be misled by the hypertension—while most forms of adrenal insufficiency present with hypotension, these specific CAH variants cause hypertension through DOC-mediated mineralocorticoid excess despite having cortisol deficiency 1, 7.

Related Questions

Which laboratory tests should be drawn at the next visit to evaluate refractory hypokalemia and differentiate primary aldosteronism from renal tubulopathies?
In a 50-year-old man with a history of renal cell carcinoma status post left nephrectomy, hypertension treated with amlodipine (Norvasc), presenting with two weeks of severe generalized weakness, dizziness, abdominal distention, hyponatremia (serum sodium 125 mmol/L) and hyperkalemia (serum potassium 5.5 mmol/L), what is the appropriate diagnostic workup and immediate management?
What is the appropriate evaluation and management for a 54-year-old male with primary hyperaldosteronism presenting with heat‑induced palpitations and generalized weakness?
What is the recommended approach to evaluate plasma aldosterone concentration and plasma renin activity (or direct renin concentration) in a patient being assessed for primary hyperaldosteronism?
In a 25-year-old man with resistant hypertension, hypokalemia, metabolic alkalosis, and a family history of stroke, which investigation is appropriate to evaluate the cause of his uncontrolled blood pressure?
Is alteplase indicated in pregnancy, and what is the recommended dosing and monitoring protocol?
Which endocrine disorders in neonates can cause hypokalemia?
What are the classifications of hypoglycemia based on timing, etiology, severity, and age group?
Can a positive direct Coombs (direct antiglobulin) test be associated with thrombotic microangiopathy?
In an adult with hyperacidity, can butamirate be used and what is the appropriate dose?
How can I become an effective, compassionate physician?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.